|
|
Biomarkers in Clinical Trials Conference is a strategic event for the pharmaceutical industry in the UK. The conference will focus on the implementation of biomarkers in drug development. It will offer a forum for the pharm professionals to identify the realities of biomarker application in late-stage drug development and explore ways of adapting existing clinical trial models to integrate biomarkers. The conference will offer the delegates an opportunity to meet with industry associates and discuss various approaches to biomarker implementation.
Biomarkers in Clinical Trials Conference 2009 will cover several topics, such as:
- The use of novel kidney biomarkers in clinical trials
- Biomarker use in early clinical decision-making
- Biomarkers coming of age: moving towards personalized medicine
- Toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring
- Biomarkers in early and late stage CNS drug development
- Discovery, validation and support of biomarkers for clinical drug trials
- High content immunoassays: the quest for biomarkers for efficacy and safety
- Personalised healthcare strategies in rheumatoid arthritis
Visitor Profile
The targeted visitors at the Biomarkers in Clinical Trials Conference 2009 are vice presidents, heads, directors, scientists and project leaders of:
- Research and Development
- Drug and Safety Assessment
- Biomarker Discovery/Validation
- Diagnostics
- Imaging
- Clinical Pharmacology
- Toxicology
- Experimental Medicine
- Translational Medicine
- Drug Metabolism
- Pharmacokinetics
- Clinical Pathology
- Molecular and Cell Biology
- Clinical Development
Organizer
SMi Group Ltd
